14 Einträge gefunden

1. Abundant expression of mTOR kinase in salivary gland tumors - potentials as therapy target?

   1. Clauditz, Till Sebastian
   2. Gontarewicz, Artur
   3. Bokemeyer, Carsten
   4. Sauter, Guido
   5. Knecht, Rainald
   6. Münscher, Adrian
   7. Wilczak, Waldemar

   2013 - Forschungsinformationssystem des UKE
2. Epidermal growth factor receptor (EGFR) in salivary gland carcinomas: potentials as therapeutic target.

   1. Clauditz, Till
   2. Gontarewicz, Artur
   3. Lebok, Patrick
   4. Tsourlakis, Maria Christina
   5. Grob, Tobias
   6. Münscher, Adrian
   7. Sauter, Guido

   2012 - Forschungsinformationssystem des UKE
3. Sharpin contributes to TNFα dependent NFκB activation and anti-apoptotic signalling in hepatocytes.

   1. Sieber, Sabrina
   2. Lange, Nicole
   3. Kollmorgen, Gwendlyn
   4. Erhardt, Annette
   5. Quaas, Alexander
   6. Gontarewicz, Artur
   7. Sass, Gabriele

   2012 - Forschungsinformationssystem des UKE - frei zugänglich
4. Morphological study of synovial changes in two-stage reconstructions of the infected hip and knee arthroplasties.

   1. Gontarewicz, Artur
   2. Niggemeyer, Oliver
   3. Tharun, Lars
   4. Grancicova, Livia
   5. Rüther, Wolfgang
   6. Zustin, Jozef

   2012 - Forschungsinformationssystem des UKE - frei zugänglich
5. Targeting aurora kinases with danusertib (PHA-739358) inhibits growth of liver metastases from gastroenteropancreatic neuroendocrine tumors in an orthotopic xenograft model.

   1. Fraedrich, Katharina
   2. Schrader, Jörg
   3. Ittrich, Harald
   4. von Amsberg, Gunhild
   5. Gontarewicz, Artur
   6. Matzat, Verena
   7. Kromminga, Arno

   2012 - Forschungsinformationssystem des UKE
6. 11q21 rearrangement is a frequent and highly specific genetic alteration in mucoepidermoid carcinoma

   1. Clauditz, Till
   2. Gontarewicz, Artur
   3. Wang, Chia-Jung
   4. Münscher, Adrian
   5. Laban, Simon
   6. Tsourlakis, Maria Christina
   7. Knecht, Rainald

   2012 - Forschungsinformationssystem des UKE
7. Functional p53 is required for effective execution of telomerase inhibition in BCR-ABL-positive CML cells.

   1. Brassat, Ute
   2. Balabanov, Stefan
   3. Bali, Daniel
   4. Dierlamm, Judith
   5. Balabanov, Melanie
   6. Hartmann, Ulrike
   7. Sirma, Hüseyin

   2011 - Forschungsinformationssystem des UKE
8. Abcg2 overexpression represents a novel mechanism for acquired resistance to the multi-kinase inhibitor Danusertib in BCR-ABL-positive cells in vitro.

   1. Balabanov, Stefan
   2. Gontarewicz, Artur
   3. von Amsberg, Gunhild
   4. Raddrizzani, Laura
   5. Balabanov, Melanie
   6. Bosotti, Roberta
   7. Moll, Jürgen

   2011 - Forschungsinformationssystem des UKE - frei zugänglich
9. Danusertib (formerly PHA-739358)--a novel combined pan-Aurora kinases and third generation Bcr-Abl tyrosine kinase inhibitor.

   1. Gontarewicz, Artur
   2. Brümmendorf, Tim

   2010 - Forschungsinformationssystem des UKE
10. Expression, epigenetic regulation, and humoral immunogenicity of cancer-testis antigens in chronic myeloid leukemia.

    1. Luetkens, Tim
    2. Schafhausen, Philippe
    3. Uhlich, Frederike
    4. Stasche, Tim
    5. Akbulak, Ruken Özge
    6. Bartels, Britta M
    7. Hildebrandt, York

    2010 - Forschungsinformationssystem des UKE
11. Aurora kinase inhibitor PHA-739358 suppresses growth of hepatocellular carcinoma in vitro and in a xenograft mouse model.

    1. Benten, Daniel
    2. Keller, Gunhild
    3. Quaas, Alexander
    4. Schrader, Jörg
    5. Gontarewicz, Artur
    6. Balabanov, Stefan
    7. Balabanov, Melanie

    2009 - Forschungsinformationssystem des UKE - frei zugänglich
12. Simultaneous targeting of Aurora kinases and Bcr-Abl kinase by the small molecule inhibitor PHA-739358 is effective against imatinib-resistant BCR-ABL mutations including T315I.

    1. Gontarewicz, Artur
    2. Balabanov, Stefan
    3. von Amsberg, Gunhild
    4. Colombo, Riccardo
    5. Graziano, Alessio
    6. Pesenti, Enrico
    7. Benten, Daniel

    2008 - Forschungsinformationssystem des UKE
13. PHA-680626 exhibits anti-proliferative and pro-apoptotic activity on Imatinib-resistant chronic myeloid leukemia cell lines and primary CD34+ cells by inhibition of both Bcr-Abl tyrosine kinase and Aurora kinases.

    1. Gontarewicz, Artur
    2. Balabanov, Stefan
    3. von Amsberg, Gunhild
    4. Panse, Jens
    5. Schafhausen, Philippe
    6. Bokemeyer, Carsten
    7. Fiedler, Walter

    2008 - Forschungsinformationssystem des UKE
14. Hypusination of eukaryotic initiation factor 5A (eIF5A): a novel therapeutic target in BCR-ABL-positive leukemias identified by a proteomics approach.

    1. Balabanov, Stefan
    2. Gontarewicz, Artur
    3. Ziegler, Patrick
    4. Hartmann, Ulrike
    5. Kammer, Winfried
    6. Copland, Mhairi
    7. Brassat, Ute

    2007 - Forschungsinformationssystem des UKE